WILLIAMS AND JENSEN, PLLC for VERTEX PHARMACEUTICALS INCORPORATED
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General education about federal policies impacting pharmaceutical development, approval, and reimbursement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARINA LYNCH New | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs |
Medical/Disease Research/Clinical Labs MED
General education about federal policies impacting pharmaceutical development, approval, and reimbursement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARINA LYNCH New | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs |
Medicare/Medicaid MMM
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs. Education about non-opioid pain therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARINA LYNCH New | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs |
Budget/Appropriations BUD
General education about policies to improve outcomes for patients with APOL-1 kidney disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARINA LYNCH New | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.